If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAviva Regulatory News (AV.)

Share Price Information for Aviva (AV.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 490.30
Bid: 490.30
Ask: 490.50
Change: 1.70 (0.35%)
Spread: 0.20 (0.041%)
Open: 489.40
High: 491.30
Low: 487.60
Prev. Close: 488.60
AV. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Probitas

4 Mar 2024 07:00

RNS Number : 4277F
Aviva PLC
04 March 2024
 

 

 

 

News Release

 

 

4 March 2024

 

 

Aviva to enter Lloyd's market via acquisition of Probitas

 

? Entry into Lloyd's market via acquisition of a high quality, fully-integrated platform

? Significantly expands market opportunity for Aviva's Global Corporate & Specialty (GCS) business

? Consistent with Aviva's strategy of executing high quality, bolt-on acquisitions in our core markets to accelerate growth in our capital-light businesses

? Strong financial returns expected, supported by disciplined underwriting and profitable growth

 

Aviva plc ("Aviva") today announces the acquisition of Probitas1 for consideration of £242 million2. The transaction includes the acquisition of Probitas's fully-integrated Lloyd's platform, encompassing its Corporate Member, Managing Agent, international distribution entities and tenancy rights to Syndicate 1492.

 

Amanda Blanc, Group Chief Executive Officer of Aviva, said:

"This acquisition is another step in our strategy to invest in Aviva's future profitable growth. Aviva's presence in the Lloyd's market opens up new opportunities to accelerate growth in our capital-light General Insurance business."

 

Entry to Lloyd's market will diversify and expand Aviva's GCS footprint

GCS is a key pillar of Aviva's UK General Insurance (GI) business and is a strategic growth segment for the Aviva Group. Additionally, it supports the Group's ambition to accelerate growth in its capital-light business units.

 

The Lloyd's market represents a major source of untapped growth for Aviva, offering access to significant in-appetite premium volumes, international licences and broader distribution networks. It will also allow Aviva to capitalise on its existing underwriting capabilities, broker relationships and capital base.

 

Given Probitas's focus on specialty lines, the transaction represents a unique opportunity for Aviva to enter the Lloyd's market via a business that is well-aligned with Aviva's strategy in terms of product, geography and risk profile.

 

Acquisition of a top performer within the Lloyd's market

Syndicate 1492 reported gross written premium (GWP) of £288m in 2023 and has delivered a 21% compound annual growth rate (CAGR) since 2019. During this period, the business has consistently been a top performer within its Lloyd's peer group, achieving an average combined ratio of 82%3. Strong growth is expected to continue during 2024, driven by favourable pricing trends, new product lines and expanded local distribution in key markets.

 

Experienced and capable management team

Probitas's experienced and capable management team will continue to run the business post-acquisition and the Probitas brand will remain in use. Aviva's ambition is to preserve the business' unique, agile culture and empower the management team to focus on delivering profitable growth.

 

Attractive financial returns underpinned by disciplined underwriting and profitable growth

Subject to regulatory approval, Aviva's intention is to provide additional capital to the Corporate Member in order to sustain Syndicate 1492's strong growth trajectory and increase the share of underwriting profits that are retained within the Probitas group.

 

The acquisition price is equivalent to c.7x estimated 2026 post-tax IFRS operating profit4 and the transaction is expected to deliver a high-teens internal rate of return (IRR). The estimated impact on the Group's Solvency II shareholder cover ratio would have been a reduction of c.3 percentage points as at 31 December 20235.

 

The acquisition is consistent with our capital management framework, which remains unchanged. Aviva continues to anticipate further regular and sustainable capital returns in the future.

 

The transaction is subject to customary closing conditions including regulatory approvals and is expected to close in mid-2024.

 

Jason Storah, Chief Executive Officer of Aviva UK & Ireland General Insurance, said:

"This is a fantastic opportunity for both Aviva and Probitas. The Probitas track record, technical expertise and high-quality team will be an excellent addition to Aviva. They will continue to run the business post-acquisition and the Probitas brand will remain. We want to preserve their unique, agile culture and support the team to focus on delivering profitable growth that will benefit from leveraging Aviva's own scale and capabilities."

 

Ash Bathia, Chief Executive Officer of Probitas, said:

"As Probitas embarks on the next stage of its evolution, it was important to find a partner with the financial strength and commitment to enable Probitas to optimise its potential and ambition to significantly scale up and diversify the business and take advantage of a unique opportunity to build one of the most successful and profitable franchises in the Lloyd's market. I am convinced that Aviva is an ideal partner and I am truly excited about being part of the Aviva Group and the opportunities ahead for our business and staff".

 

 

 

-ends-

 

1 Acquisition of 100% of Probitas Holdings (Bermuda) Limited, including its subsidiaries ("Probitas").

2 Total consideration of £242m, as at 31 December 2023.

3 Historical financial metrics as disclosed within Syndicate 1492 audited Annual Reports.

4 Pro-forma basis, assuming 100% capital alignment of Syndicate 1492 from the 2025 Year of Account.

5 Estimated Solvency II shareholder cover ratio impact subject to finalising the acquisition balance sheet and capital treatment.

 

 

Enquiries:

 

Media:

 

Andrew Reid +44 (0)7800 694 276

Sarah Swailes +44 (0)7800 694 859

Marion Fischer +44 (0)7800 693 219

 

Analysts:

 

Rupert Taylor Rea +44 (0)7385 494 440

Joel von Sternberg +44 (0)7384 231 238

Michael O'Hara +44 (0)7387 234 388

 

Notes to editors:

· We are the UK's leading Insurance, Wealth & Retirement business and we operate in the UK, Ireland and Canada. We also have international investments in India and China.

· We help our 18.7 million customers make the most out of life, plan for the future, and have the confidence that if things go wrong we'll be there to put it right.

· We have been taking care of people for more than 325 years, in line with our purpose of being 'with you today, for a better tomorrow'. In 2022, we paid £23.2 billion in claims and benefits to our customers.

· In 2021, we announced our ambition to become Net Zero by 2040, the first major insurance company in the world to do so. We are aiming to have a cut of 25% in the carbon intensity of our investments by 2025 and of 60% by 2030; and Net Zero carbon emissions from our own operations and supply chain by 2030. While we are working towards our sustainability ambitions, we acknowledge that we have relationships with businesses and existing assets that may be associated with significant emissions. Find out more about our climate goals at www.aviva.com/climate-goals and our sustainability ambition and action at www.aviva.com/sustainability

· Aviva is a Living Wage, Living Pension and Living Hours employer and provides market-leading benefits for our people, including flexible working, paid carers leave and equal parental leave. Find out more at https://www.aviva.com/about-us/our-people/

· As at 30 June 2023, total Group assets under management at Aviva Group were £358 billion and our estimated Solvency II shareholder capital surplus as at 30 September 2023 was £7.6 billion. Our shares are listed on the London Stock Exchange and we are a member of the FTSE 100 index.

· For more details on what we do, our business and how we help our customers, visit www.aviva.com/about-us

· The Aviva newsroom at www.aviva.com/newsroom includes links to our spokespeople images, podcasts, research reports and our news release archive. Sign up to get the latest news from Aviva by email.

· You can follow us on:

X: www.x.com/avivaplc

LinkedIn: www.linkedin.com/company/aviva-plc 

Instagram: www.instagram.com/avivaplc

· For the latest corporate films from around our business, subscribe to our YouTube channel: www.youtube.com/user/aviva 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQQKQBDABKKFNK
Date   Source Headline
16th Oct 20235:34 pmRNSHolding(s) in Company
12th Oct 20233:00 pmRNSDirector/PDMR Shareholding
11th Oct 20233:40 pmRNSTR-1: Notification of major holdings
10th Oct 20232:42 pmRNSDirector/PDMR Shareholding
2nd Oct 20234:30 pmRNSHolding(s) in Company
29th Sep 202310:53 amRNSTotal Voting Rights
28th Sep 20232:48 pmRNSDirector/PDMR Shareholding
26th Sep 20232:40 pmRNSHolding(s) in Company
26th Sep 202312:00 pmRNSDirector/PDMR Shareholding
25th Sep 20231:29 pmRNSDirector/PDMR Shareholding
25th Sep 20237:00 amRNSAviva to acquire AIG's protection business
22nd Sep 20233:40 pmRNSHolding(s) in Company
21st Sep 20237:00 amRNSHolding(s) in Company
20th Sep 20237:00 amRNSHolding(s) in Company
15th Sep 20233:24 pmRNSHolding(s) in Company
15th Sep 20231:09 pmRNSDirector/PDMR Shareholding
14th Sep 20232:25 pmRNSHolding(s) in Company
13th Sep 20237:00 amRNSDisposal
11th Sep 20233:29 pmRNSEMTN Supplementary Prospectus
31st Aug 20239:42 amRNSTotal Voting Rights
23rd Aug 20231:14 pmRNSDirector/PDMR Shareholding
18th Aug 20232:25 pmRNSTR-1: Notification of major holdings
17th Aug 20239:57 amRNSDirector/PDMR Shareholding
16th Aug 20233:50 pmRNSTR-1: Notification of major holdings
16th Aug 20237:01 amRNSDividend Declaration
16th Aug 20237:00 amRNSAviva plc Half Year Report 2023
15th Aug 20232:28 pmRNSDirector/PDMR Shareholding
14th Aug 20232:46 pmRNSTR-1: Notification of major holdings
14th Aug 202312:32 pmRNSHolding(s) in Company
8th Aug 20234:36 pmRNSRETRACTION OF STANDARD TR-1 FORM
8th Aug 20233:45 pmRNSTR-1: NOTIFICATION OF MAJOR HOLDINGS
7th Aug 20239:37 amRNSTR-1: Notification of major holdings
3rd Aug 20232:37 pmRNSForm 8.3 - CT Property Trust Limited
3rd Aug 20232:37 pmRNSForm 8.3 - Blancco Technology Group plc
2nd Aug 20232:23 pmRNSForm 8.3 - LondonMetric Property plc
31st Jul 202311:43 amRNSTotal Voting Rights
19th Jul 20237:00 amRNSAviva 2022 comparative results IFRS 17 and IFRS 9
18th Jul 20233:00 pmRNSForm 8.3 - Gresham House
18th Jul 202310:11 amRNSDirector/PDMR Shareholding
18th Jul 20239:34 amRNSDirector/PDMR Shareholding
14th Jul 202312:12 pmRNSResults of a noteholders’ meeting
11th Jul 20232:24 pmRNSBlock listing Interim Review
6th Jul 202311:57 amRNSCancellation of listing of 6.125% Tier 2 Notes
5th Jul 20232:19 pmRNSTR-1: Notification of major holdings
4th Jul 20239:18 amRNSTR1: Notification of Major Holdings
3rd Jul 20233:54 pmRNSTR-1: Notification of major holdings
30th Jun 202312:10 pmRNSTotal Voting Rights
28th Jun 20233:14 pmRNSDirector/PDMR Shareholding
28th Jun 20232:21 pmRNSDirector/PDMR Shareholding
22nd Jun 20234:24 pmRNSNotice of Meeting - Aviva Tier 2 Notes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.